Full-Time

Associate Omnichannel Marketing Director

Posted on 11/13/2024

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Healthcare

Compensation Overview

$167k - $241.9kAnnually

+ Annual Bonus + Equity Incentive Program

Senior

Remote in USA

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Data Analysis
Requirements
  • BS/BA degree in marketing, communications, or life sciences and 10+ years of experience in digital or omnichannel marketing OR
  • Master's degree in marketing, life sciences or business administration and 8+ years of similar experience as noted above
  • Understanding of compliance and regulatory related concepts that govern biopharmaceutical commercial activities, or similar experience from other regulated industries
  • Understanding and demonstrated experience with marketing in industries with complex buying processes (B2B, account-based, etc)
  • Strong knowledge of marketing fundamentals with ability to align brand marketing and customer behavioral objectives to a comprehensive strategy that encompasses customer segmentation, channel-mix, and content strategy
  • Expert analytical skills with the ability to interpret data and make data-driven decisions
  • Proven ability to assess and synthesize insights to inform customer engagement strategy and journey design through persuasive storytelling that brings meaningful and actionable context to drive more data-driven decision making
  • Emerging as an internal thought leader with technical and/or business expertise
  • Applies in-depth knowledge of own area of expertise to solve problems
  • Applies expertise to manage critical projects and/or relationships
  • Integrates analysis of business objectives and strategic direction to resolve problems and recommend solutions
  • Has input into short-term strategy and may be involved in long-term strategy on a functional level
  • Strong communications, problem-solving, analytical thinking, influencing skills
Responsibilities
  • Establish trust and credibility with Brand Marketing as a data-driven customer engagement expert that provides critical knowledge to propel the strategic imperatives of the brand forward
  • Perform in-depth analysis of behavioral and attitudinal customer insights to inform optimal engagement opportunities and channel-mix investment choices
  • Collaboratively design customer engagement journeys for customer segments to drive personalization with the right channels and content that are based on a deep understanding of the customer and the brand strategic imperatives
  • Support the creation of cross-channel customer engagements through detailed campaign design, business rules, measures, and required metadata to support measurement and analytics
  • Collaborate with key stakeholders (Marketing, Analytics, Sales) and agencies/vendors (media, third party program partners, etc.) to recommend channel investments
  • Define success measures for omnichannel campaigns and monitor performance against objectives while in-flight and retrospectively
  • Partner with Insights & Analytics to understand the business impact of campaigns and uncover insights to drive continuous optimization
  • Educate and upskill the brand teams and other stakeholders on customer engagement strategies, frameworks, and omnichannel capabilities as required
  • Provide input to help shape the evolution of capabilities that improve customer engagement and business growth
  • Document and share omnichannel best practices to reinforce learnings and successful outcomes
  • Performs other duties as assigned
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approval of CRENESSITY supports Neurocrine's innovative drug development strategy.
  • Partnership with PANTHERx Rare enhances patient access and support for CRENESSITY.
  • Neurocrine's focus on rare diseases aligns with industry trends towards first-in-class therapies.

What critics are saying

  • Increased competition in CAH treatments could impact Neurocrine's market share.
  • Reliance on PANTHERx Rare for distribution poses operational disruption risks.
  • Potential side effects of CRENESSITY could lead to regulatory scrutiny or reduced adoption.

What makes Neurocrine Biosciences unique

  • CRENESSITY is the first non-steroidal treatment for classic congenital adrenal hyperplasia.
  • Neurocrine's CRENESSITY offers a novel approach with selective CRF1 receptor antagonism.
  • CRENESSITY is the first new CAH treatment in 70 years, marking a significant advancement.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE